SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001193125-22-289176
Filing Date
2022-11-21
Accepted
2022-11-18 17:39:30
Documents
9

Document Format Files

Seq Description Document Type Size
1 F-1 d423556df1.htm F-1 320519
2 EX-5.1 d423556dex51.htm EX-5.1 39686
3 EX-21.1 d423556dex211.htm EX-21.1 3970
4 EX-23.1 d423556dex231.htm EX-23.1 2272
5 EX-FILING FEES d423556dexfilingfees.htm EX-FILING FEES 43178
6 GRAPHIC g423556g03s01.jpg GRAPHIC 13722
7 GRAPHIC g423556g13s02.jpg GRAPHIC 76254
8 GRAPHIC g423556g33s03.jpg GRAPHIC 13733
9 GRAPHIC g423556g48s04.jpg GRAPHIC 3747
  Complete submission text file 0001193125-22-289176.txt   559177
Mailing Address 30 BROADWICK STREET LONDON X0 W1F 8LX
Business Address 30 BROADWICK STREET LONDON X0 W1F 8LX 44 020 7788 7414
Virax Biolabs Group Ltd (Filer) CIK: 0001885827 (see all company filings)

IRS No.: 000000000
Type: F-1 | Act: 33 | File No.: 333-268486 | Film No.: 221402988
SIC: 2835 In Vitro & In Vivo Diagnostic Substances